Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. India
  4. Bombay Stock Exchange
  5. Hikal Limited
  6. Summary
    524735   INE475B01022

HIKAL LIMITED

(524735)
  Report
 SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote Bombay Stock Exchange
11/23/2021 11/24/2021 11/25/2021 11/26/2021 11/29/2021 Date
531.5 525.75 535.85 502.15 492.15 Last
61824 43307 18149 53432 19780 Volume
+6.73% -1.08% +1.92% -6.29% -1.99% Change
Estimated financial data (e)
Sales 2022 19 681 M 262 M 262 M
Net income 2022 2 026 M 27,0 M 27,0 M
Net Debt 2022 - - -
P/E ratio 2022 29,9x
Yield 2022 0,18%
Sales 2023 22 484 M 300 M 300 M
Net income 2023 2 474 M 33,0 M 33,0 M
Net Debt 2023 - - -
P/E ratio 2023 24,5x
Yield 2023 0,18%
Capitalization 60 682 M 808 M 809 M
Capi. / Sales 2022 3,08x
Capi. / Sales 2023 2,70x
Nbr of Employees -
Free-Float 31,0%
More Financials
Company
Hikal Limited is engaged in the manufacturing of various chemical intermediates, specialty chemicals, active pharmaceutical ingredients (APIs) and contract research activities. The Company offers pharmaceuticals and agrochemicals. Its segments include Crop Protection and Pharmaceuticals. It offers agrochemicals, including active ingredients, such as Ammonium dithiocarbamate, Amitrole Tech, Diuron Tech, Ethion Tech,... 
Sector
Pharmaceuticals
Calendar
02/02Earnings Release
More about the company
Ratings of Hikal Limited
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
-
More Ratings
All news about HIKAL LIMITED
11/24HIKAL : Related Party Transactions on a consolidated basis for the half year ended 30th Se..
PU
10/27Hikal Clocks 63% Increase in Consolidated Net Profit in Fiscal Q2
MT
10/26Hikal Results Presentation FY22Q2
PU
10/26Hikal Results FY22Q2
PU
10/26Hikal Limited Reports Earnings Results for the Second Quarter and Six Months Ended Sept..
CI
10/13HIKAL : Annual Return- 2020-21 (MGT-7)
PU
09/21HIKAL : Transcript of 33rd AGM 2021
PU
09/20HIKAL LIMITED(BSE : 524735) added to S&P Global BMI Index
CI
09/02Hikal Limited Announces Executive Changes
CI
09/02Hikal Limited Approves to Declare a Final Dividend for the Financial Year 2020 to 2021
CI
08/25HIKAL LIMITED : Ex-dividend day for final dividend
FA
08/18Hikal Limited Resumes Operations At Manufacturing Unit At Mahad
CI
08/05HIKAL : Consolidated Net Profit Soars in Fiscal Q1
MT
08/05Hikal Limited Reports Earnings Results for the First Quarter Ended June 30, 2021
CI
07/24Hikal Limited Temporarily Halts Operations At Manufacturing Unit At Mahad
CI
More news
News in other languages on HIKAL LIMITED
10/27Hikal enregistre une hausse de 63 % de son bénéfice net consolidé au deuxième trimestre..
09/02Hikal Limited approuve la déclaration d'un dividende final pour l'exercice 2020 à 2021
More news
Chart HIKAL LIMITED
Duration : Period :
Hikal Limited Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends HIKAL LIMITED
Short TermMid-TermLong Term
TrendsNeutralNeutralBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 3
Last Close Price 492,15 INR
Average target price 621,67 INR
Spread / Average Target 26,3%
EPS Revisions
Managers and Directors
Sameer Jai Hiremath Managing Director & Director
Kuldeep Jain Chief Financial Officer
Jai Vishwanath Hiremath Executive Chairman
Rajasekhar Reddy Secretary & Compliance Officer
Kannan Kadankote Unni Independent Non-Executive Director
Sector and Competitors
1st jan.Capi. (M$)
HIKAL LIMITED198.73%825
JOHNSON & JOHNSON1.16%419 109
ROCHE HOLDING AG16.05%336 162
PFIZER, INC.46.70%303 095
NOVO NORDISK A/S67.00%247 254
ELI LILLY AND COMPANY54.21%236 049